Interestingly, inhibition of NHE1 protein with HOE642 decreased the accumulation of tumor-associated macrophages and cytokine secretion, but enhanced the anti-tumor immunity and immunotherapy of anti-PD-1 in mouse glioma models. This evidence concerns the gene SLC9A1 and central nervous system cancer.